C07K

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Subclasses

Not Available
Subclass Title
1/00 General processes for the preparation of peptides
1/02 General processes for the preparation of peptides in solution
1/04 General processes for the preparation of peptides on carriers
1/06 General processes for the preparation of peptides using protecting groups or activating agents
1/08 General processes for the preparation of peptides using protecting groups or activating agents using activating agents

more results

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
9603895 Cyclosporin analogues for preventing or treating hepatitis C infection Sep 02, 15 Mar 28, 17 , ENANTA PHARMACEUTICALS, INC.
9603897 Methods for treating tissue damage associated with ischemia with apolipoprotein D Mar 12, 13 Mar 28, 17 , MASSACHUSETTS INSTITUTE OF TECHNOLOGY
9603898 Formulations of diluted amino acid segments and methods for making same Mar 23, 12 Mar 28, 17 , DESERET BIOLOGICALS, INC.
9603901 Treatment of short bowel syndrome patients with colon-in-continuity Oct 05, 16 Mar 28, 17 , SHIRE-NPS PHARMACEUTICALS, INC.
9603902 Treatment of short bowel syndrome patients with colon-in-continuity Oct 05, 16 Mar 28, 17 , SHIRE-NPS PHARMACEUTICALS, INC.
9603904 Treating diabetes melitus using insulin injections with less than daily injection frequency Oct 29, 09 Mar 28, 17 , NOVO NORDISK A/S
9603911 Ribotoxin molecules derived from sarcin and other related fungal ribotoxins Mar 03, 14 Mar 28, 17 , RESEARCH CORPORATION TECHNOLOGIES INC.
9603914 and uses thereof Aug 02, 13 Mar 28, 17 , VITAMFERO
9603915 infection Feb 14, 14 Mar 28, 17 , THE BOARD OF TRUSTEES OF THE UNIVERSITY OF AKANSAS; THE TEXAS A&M UNIVERSITY SYSTEM;
9603916 Treatment and prevention of malaria Nov 09, 15 Mar 28, 17 , OXFORD UNIVERSITY INNOVATION LIMITED
9603917 Immunologically active compositions Aug 24, 15 Mar 28, 17 , GALENBIO, INC.
9603919 Method for prophylaxis of influenza using vaccine for intranasal administration Mar 31, 10 Mar 28, 17 , JAPAN AS REPRESENTED BY THE DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES; THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY; TOKO YAKUHIN KOGYO KABUSHIKI KAISHA;
9603920 Compositions and methods for treating influenza Jan 23, 14 Mar 28, 17 , VARIATION BIOTECHNOLOGIES, INC.
9603923 Universal carrier for targeting molecules to GB3 receptor expressing cells Sep 05, 14 Mar 28, 17 , (1) IMSTAR IMAGE ET MODELISATION: STRATEGIE ANALYSE ET REALISATION (2) INSTITUT CURIE (ET AL); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); UNIVERSITE PIERRE ET MARIE CURIE (PARIS VI);
9603925 Compositions comprising TL1A-Ig fusion protein for the regulation of T regulatory cells, and methods for their use Feb 20, 14 Mar 28, 17 , UNIVERSITY OF MIAMI
9603934 Anhydrous hydrogel composition and delivery system May 16, 14 Mar 28, 17 , ACUPAC PACKAGING INC.
9603942 Somatostatin-dopamine chimeric analogs Feb 05, 15 Mar 28, 17 , IPSEN PHARMA S.A.S.
9603946 Peptide sequence design and use thereof for peptide-mediated siRNA delivery Dec 29, 15 Mar 28, 17 , POSITEC POWER TOOLS (SUZHOU) CO. LTD.;
9604073 Light-sensitive ion-passing molecules May 12, 16 Mar 28, 17 , THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
9604907 Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics Jan 27, 14 Mar 28, 17 , THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS;

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2017/0079,251 GENETICALLY MODIFIED ANIMALS HAVING INCREASED HEAT TOLERANCE Sep 20, 16 Mar 23, 17 , Not available
2017/0079,253 TRANSGENIC MICE HAVING A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PHENOTYPE, EXPERIMENTAL USES AND APPLICATIONS Jul 17, 12 Mar 23, 17 , INSTITUT PASTEUR
2017/0081,300 SYDNONE DERIVATIVES FOR CONJUGATION OF COMPOUNDS OF INTEREST May 15, 15 Mar 23, 17 , Not available
2017/0081,358 METHODS AND SYSTEMS FOR SOLID PHASE PEPTIDE SYNTHESIS Sep 16, 16 Mar 23, 17 , MASSACHUSETTS INSTITUTE OF TECHNOLOGY
2017/0081,359 SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS Sep 16, 16 Mar 23, 17 , MASSACHUSETTS INSTITUTE OF TECHNOLOGY
2017/0081,360 Chemically Modifying Peptides May 28, 15 Mar 23, 17 , Not available
2017/0081,361 HYDROXYSTATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS Nov 30, 16 Mar 23, 17 , MERCK PATENT GMBH
2017/0081,362 Inhibitor of Apoptosis Protein (IAP) Antagonists Nov 29, 16 Mar 23, 17 , Not available
2017/0081,363 PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES Dec 23, 14 Mar 23, 17 , Not available
2017/0081,364 NOVEL ANTIMICROBIAL PEPTIDES AND THEIR APPLICATION Mar 10, 15 Mar 23, 17 , INFINITEC ACTIVOS S.L.
2017/0081,366 Novel Peptides for Preventing or Treating Bone Diseases and Use Thereof Nov 10, 15 Mar 23, 17 , Not available
2017/0081,367 PEPTIDES FOR PREVENTING OR TREATING BONE DISEASES AND USE THEREOF Nov 10, 15 Mar 23, 17 , Not available
2017/0081,368 PEPTIDES AS OXYTOCIN AGONISTS Dec 05, 16 Mar 23, 17 , HOFFMANN-LA ROCHE, INC.
2017/0081,369 PEPTIDES AS OXYTOCIN AGONISTS Dec 02, 16 Mar 23, 17 , HOFFMANN-LA ROCHE, INC.
2017/0081,370 METHOD FOR TREATING PROSTATITIS UTILIZING PORE-FORMING PROTEIN PROAEROLYSIN Sep 30, 16 Mar 23, 17 , Not available
2017/0081,371 FLUORESCENT AND COLORED PROTEINS AND METHODS FOR USING THEM Sep 29, 16 Mar 23, 17 , Not available
2017/0081,372 EXPRESSION OF CHIMERIC KSAC PROTEIN AND METHOD OF PRODUCING SOLUBLE PROTEINS BY HIGH PRESSURE Feb 05, 16 Mar 23, 17 , MERIAL, INC.
2017/0081,373 TARGETING OF CHONDROITIN SULFATE GLYCANS Oct 05, 16 Mar 23, 17 , VAR2 PHARMACEUTICAL APS
2017/0081,374 TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS Nov 10, 16 Mar 23, 17 , Not available
2017/0081,375 GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, RENAL NEPHRONS AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR Dec 05, 16 Mar 23, 17 , Not available

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to follow the Technologies/Sub-Technologies.